Skip to content

NEUROPLAST

Active Private limited companyfounded 2008active for 17 yearsRoute d'Obourg 73, 7000 MonsKBO/BCE: BE 0807.910.723

Lifetime

17 annual accounts with figures on one time axis
peak of €168,484 in 2025
€168,484▲ 30.1%
lowest -€129,837 in 2009
-€231▼ €33,335
peak of €219,027 in 2017
€199,460▼ 0.1%
€1.4m▲ 54.7%
Board3 names since 2019
3 directors and 2 others
Owners2 names in the annual accounts
  
Documentsfilings and deeds
02-07-202629 days before the deadline
2025abbreviated format
Gross margin from €129,501 to €168,484Loss of €231Debts from €905,253 to €1.4mInvestments €747,704Cash from €174,135 to €15,849

Key points

from the 2025 annual accounts

Turnover

≈ €310,000 estimated

The accounts state no turnover.

Debts

€1.4m 88% of the balance sheet
Financial debts 64%Suppliers 1%Taxes and wages 3%Other 32%

Of this, €495,987 falls due within a year.

Investments

€747,704 6.8 times depreciation
20212022202320242025

Green is investment, beige is depreciation. Land and buildings stand 80.7% higher than in 2024.

Liquidity

0.29 was 2.13 in 2024

Short-term debts rose from €133,750 to €495,987.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

The last five annual accounts were filed 28 to 31 days before the end of the period.

Position in the sector

-€231

Lower net result than 89% of companies in human health. Sector median €125,115 · 2,774 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,425 companies had the same profile as NEUROPLAST has now. Each dot stands for 4 companies, two years later.

96.5%
were still trading
2.2%
stopped another way
1.0%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a small loss

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,425 companies, not a prediction for NEUROPLAST. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Director
  • 50%annual accounts 2021
  • 50%annual accounts 2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0807910723
Registered office moved from Auderghem to Mons The registered office moved from Avenue Charles Schaller 32A à 1160 Auderghem to Route d'Obourg 73 7000 Mons · Board meeting of 16-09-2024 · Gazette deed
(director) and (director) appointed Gazette deed
(manager) and (manager) reappointed General meeting of 28-11-2018 · Gazette deed
All 30 events

Comparable companies

same main activity, similar in size and age
Company
NEUROPLAST Mons €1.6m €168,484 12.5% -
OCULOMED Enghien €1.6m €193,257 78.7% -
DOCTEUR DANIELE MALAISE Liège €1.4m €181,982 89.9% -
PLASTIPEDIA Seneffe €1.4m €156,178 40.4% -
CMTC Enghien €1.6m €218,671 64.6% -
HUYLEBROEK.SPORTSMED-SPORTTRAUMATOLOGIE EN ORTHOPEDIE Wemmel €1.6m €141,787 93.3% -
ORTHOPEDIE Dr. Van den Bogaert Max I.J. Rumst €1.9m €154,561 14.4% -

These companies have the same main activity as NEUROPLAST: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.4m and €1.9m, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 21-11-2008Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.191.054.5097000 Mons, registered on 21-11-2008
Financial year end
31 December
Peppol
Reachable since 14-11-2025
Company details

Annual accounts 2025

€1.6m▲ 44.8%
Filing
Filed on 02-07-2026, 29 days before the end of the filing period
Financials

Insights on NEUROPLAST

NEUROPLAST files the abbreviated format. That format states no turnover. The gross margin rose from -€66,765 in 2009 to €168,484 in 2025.

The balance sheet grew most from 2023 to 2025 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEUROPLAST

What is the company number of NEUROPLAST?
The company number of NEUROPLAST is 0807.910.723. The VAT number is the same number with BE in front: BE 0807.910.723.
Where is NEUROPLAST based?
The registered office is at Route d'Obourg 73, 7000 Mons.Company details
What does NEUROPLAST do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of NEUROPLAST?
NEUROPLAST is a private limited company (BV).
When was NEUROPLAST founded?
NEUROPLAST was founded on 21-11-2008.
Is NEUROPLAST still active?
Yes, NEUROPLAST is an active enterprise in the KBO register.
What is the turnover of NEUROPLAST?
The turnover in financial year 2025 is ≈ €310,000. This figure is estimated from the gross margin of €168,484 and 40 comparable companies (NACE 86220). It probably lies between €270,000 and €420,000.Financials
Is NEUROPLAST profitable?
In financial year 2025, NEUROPLAST made a loss of €231.
Where can I find the annual accounts of NEUROPLAST?
NEUROPLAST filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEUROPLAST due?
NEUROPLAST must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.